tiprankstipranks
Trending News
More News >
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market

Benitec Biopharma (BNTC) Ratios

Compare
310 Followers

Benitec Biopharma Ratios

BNTC's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, BNTC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
46.95 10.49 0.94 1.90 15.05
Quick Ratio
46.95 10.49 0.93 1.90 15.05
Cash Ratio
46.66 10.33 0.62 1.60 14.44
Solvency Ratio
-17.26 -4.31 -4.50 -5.88 -9.76
Operating Cash Flow Ratio
-11.04 -3.94 -4.53 -6.28 -9.37
Short-Term Operating Cash Flow Coverage
-53.99 -68.32 0.00 0.00 0.00
Net Current Asset Value
$ 92.65M$ 46.71M$ -533.00K$ 1.73M$ 19.24M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.13 0.14 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 2.77 0.28 0.01
Debt-to-Capital Ratio
<0.01 <0.01 0.73 0.22 0.01
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.03 1.11 22.10 2.07 1.07
Debt Service Coverage Ratio
-112.56 -75.38 -566.76 -569.00 -2.25K
Interest Coverage Ratio
0.00 0.00 -578.21 -557.94 -2.27K
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.02 0.03 0.21 0.88 0.43
Net Debt to EBITDA
2.01 2.36 0.10 0.18 1.44
Profitability Margins
Gross Profit Margin
16.37%50.00%-408.00%87.67%-108.47%
EBIT Margin
-6601.80%-10069.91%-25441.33%-24898.63%-23518.64%
EBITDA Margin
-8381.29%-9911.11%-24933.33%-24457.53%-23044.07%
Operating Profit Margin
-8233.27%-10412.04%-25441.33%-24457.53%-23044.07%
Pretax Profit Margin
-7522.12%-10069.91%-26082.67%-24942.47%-23528.81%
Net Profit Margin
-7522.12%-10069.91%-26082.67%-25427.40%-23357.63%
Continuous Operations Profit Margin
-5909.71%-10069.91%-26082.67%-24942.47%-23528.81%
Net Income Per EBT
100.00%100.00%100.00%101.94%99.27%
EBT Per EBIT
91.36%96.71%102.52%101.98%102.10%
Return on Assets (ROA)
-43.55%-41.66%-438.22%-310.77%-64.46%
Return on Equity (ROE)
-45.91%-46.04%-9684.16%-644.07%-68.87%
Return on Capital Employed (ROCE)
-48.70%-47.56%-3926.13%-518.86%-67.95%
Return on Invested Capital (ROIC)
-48.48%-47.00%-2507.74%-492.85%-66.74%
Return on Tangible Assets
-43.55%-41.66%-438.22%-310.77%-64.46%
Earnings Yield
-7.79%-29.20%-173.84%-97.91%-37.74%
Efficiency Ratios
Receivables Turnover
0.00 0.94 0.00 24.33 2.36
Payables Turnover
0.00 0.08 0.33 0.02 0.45
Inventory Turnover
0.00 0.00 29.31 5.00K 0.00
Fixed Asset Turnover
0.64 0.48 0.12 0.07 0.10
Asset Turnover
<0.01 <0.01 0.02 0.01 <0.01
Working Capital Turnover Ratio
<0.01 <0.01 0.07 <0.01 <0.01
Cash Conversion Cycle
0.00 -4.18K -1.08K -17.10K -658.43
Days of Sales Outstanding
0.00 386.97 0.00 15.00 154.66
Days of Inventory Outstanding
0.00 0.00 12.45 0.07 0.00
Days of Payables Outstanding
0.00 4.57K 1.09K 17.11K 813.09
Operating Cycle
0.00 386.97 12.45 15.07 154.66
Cash Flow Ratios
Operating Cash Flow Per Share
-0.54 -1.89 -6.50 -16.54 -25.39
Free Cash Flow Per Share
-0.54 -1.91 -6.50 -16.55 -25.83
CapEx Per Share
<0.01 0.02 <0.01 0.01 0.44
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
-3.73K -108.40 -18.01K -1.22K -58.06
Capital Expenditure Coverage Ratio
-3.73K -108.40 -18.01K -1.22K -58.06
Operating Cash Flow Coverage Ratio
-27.36 -68.32 -32.22 -19.60 -60.24
Operating Cash Flow to Sales Ratio
-40.20 -89.83 -240.16 -217.79 -217.49
Free Cash Flow Yield
-6.59%-26.29%-160.08%-83.93%-35.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-12.84 -3.43 -0.58 -1.02 -2.65
Price-to-Sales (P/S) Ratio
610.39 344.90 150.04 259.70 618.83
Price-to-Book (P/B) Ratio
5.74 1.58 55.71 6.58 1.82
Price-to-Free Cash Flow (P/FCF) Ratio
-15.18 -3.80 -0.62 -1.19 -2.80
Price-to-Operating Cash Flow Ratio
-24.02 -3.84 -0.62 -1.19 -2.85
Price-to-Earnings Growth (PEG) Ratio
-0.71 0.04 <0.01 0.03 0.04
Price-to-Fair Value
5.74 1.58 55.71 6.58 1.82
Enterprise Value Multiple
-5.27 -1.12 -0.50 -0.88 -1.25
Enterprise Value
245.71M 23.92M 9.33M 15.71M 16.95M
EV to EBITDA
-5.27 -1.12 -0.50 -0.88 -1.25
EV to Sales
441.93 110.72 124.46 215.17 287.37
EV to Free Cash Flow
-10.99 -1.22 -0.52 -0.99 -1.30
EV to Operating Cash Flow
-10.99 -1.23 -0.52 -0.99 -1.32
Tangible Book Value Per Share
2.25 4.60 0.07 3.00 39.60
Shareholders’ Equity Per Share
2.25 4.60 0.07 3.00 39.60
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 -0.02 <0.01
Revenue Per Share
0.01 0.02 0.03 0.08 0.12
Net Income Per Share
-1.01 -2.12 -7.06 -19.31 -27.27
Tax Burden
1.00 1.00 1.00 1.02 0.99
Interest Burden
1.14 1.00 1.03 1.00 1.00
Research & Development to Revenue
32.58 72.26 170.32 154.41 118.98
SG&A to Revenue
49.75 31.07 85.09 91.04 110.37
Stock-Based Compensation to Revenue
39.88 3.84 6.03 11.92 10.75
Income Quality
0.53 0.89 0.92 0.87 0.92
Currency in USD